LONDON: Surgical Innovations Group plc (AIM: SUN) has launched YelloPort Elite 5mm, a new surgical Port Access System, developed in partnership with CMR Surgical (‘CMR’), a global medical devices company dedicated to transforming surgery with Versius, a next-generation surgical robot.
Under the design agreement Surgical Innovations and CMR have signed, the Company will supply the ResposableTM item for each installed CMR Surgical’s Versius Robotic Systemâ.
The new YelloPort Elite 5mm product was designed specifically for CMR Surgical’s Versius Robotic Systemâ, though it is universal in nature and can be used in combination with a wider range of laparoscopic instrumentation including other robotic systems.
The device is designed to function effectively with robotic instrumentation and addresses the continuing need for high-quality cost-effective solutions within laparoscopy surgery, utilising the Company’s Resposable technology to meet these clinical needs. YelloPort Elite 5mm received its CE mark in February 2022 and will be available globally from April 2022.
This is the first project that Surgical Innovations and CMR Surgical, two British-based medical device companies, have collaborated on. Both target international healthcare markets.
Mark Slack, Chief Medical Officer, CMR Surgical, said: “When we talk to hospitals and clinical teams, we hear how important it is for them to reduce the environmental impact of the surgical products and instruments they use. We want to partner with hospitals to reduce waste and cost, whilst advancing performance. Working with Surgical Innovations to develop this new port, for use with our robotic systems, we’ve been able to do just that.”
David Marsh, Chief Executive Officer of Surgical Innovations (www.sigroupplc.com), said: “We’re delighted to partner with CMR Surgical, a fellow British medical device company focused in minimally invasive surgery, to develop this new surgical Port Access System. Our Resposable products provide a high-quality hybrid instrument concept, with the clinical benefits of a small disposable element, reducing waste by at least 70% compared to fully disposable alternatives. The project with CMR also creates opportunity to develop greater partnerships in robotic surgery and utilises our existing experience in access devices, instrumentation and flex technology.”